Our results highlight that the activation of PINK1/Parkin-mediated mitophagy to suppress pyroptosis via the Nrf2 pathway may serve as a potential therapeutic target for CDDO-Im in alleviating sepsis-induced ARDS. The gene discussed is PRKN; the disease is acute respiratory distress syndrome.